PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
Abstract PAM50 intrinsic subtyping and risk of recurrence (ROR) score are approved for risk profiling in postmenopausal women. We aimed to examine their long-term prognostic value in terms of breast cancer-free interval (BCFi) and overall survival (OS) (n = 437) in premenopausal women randomised to...
Main Authors: | Christine Lundgren, Pär-Ola Bendahl, Sarah E. Church, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-022-00423-z |
Similar Items
-
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
by: Christine Lundgren, et al.
Published: (2023-09-01) -
PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
by: Charlotte Levin Tykjær Jørgensen, et al.
Published: (2021-03-01) -
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
by: Maria Inasu, et al.
Published: (2021-09-01) -
The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance
by: Ulrik Narbe, et al.
Published: (2020-07-01) -
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer
by: Carina Forsare, et al.
Published: (2022-02-01)